Extended, standard, or De-escalation antiplatelet therapy for patients with coronary artery disease undergoing percutaneous coronary intervention? A trial-sequential, bivariate, influential, and network meta-analysis

Post time 2022-8-11 18:42:21

journal：European Heart Journal - Cardiovascular Pharmacotherapy

Authors：Waqas Ullah; Salman Zahid; Harigopal Sandhyavenu; Mohammed Faisaluddin; Fouad Khalil; Ahmad K Pasha; M Chadi Alraies; Thomas Cuisset; Sunil V Rao; Pierre Sabouret; Michael P Savage; David L Fischman

Published date：--

DOI：10.1093/ehjcvp/pvac020

Article link：http://dx.doi.org/10.1093/ehjcvp/pvac020

Article Source：Oxford University Press (OUP)。

Remark：

Post time 2022-8-11 18:42:22

: This post has been completed
Completed attachments will be deleted within 24 hours.

Post time 2022-8-11 18:45:25

: This post has been completed
Completed attachments will be deleted within 24 hours.

[Oxford] Extended, standard, or De-escalation antiplatelet therapy for patients with coronary artery disease undergoing percutaneous coronary intervention? A trial-sequential, bivariate, influential, and network meta-analysis

Best Answer

Same Category

Latest Reply

Announcement

Enthusiastic users today